Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Pharmaceutical Executive October 1, 2012	Country Report: Turkey In the global theater of business and politics, Turkey increasingly leverages its location as an ideal vantage point where actors can seamlessly move between all things West and East. The pharmaceutical industry has also enjoyed a wave of expansion.
Pharmaceutical Executive October 1, 2011 William Looney	The East is Up Candan Karabagli is CEO of Turkey's largest pharmaceutical company, Abdi Ibrahim, where she is responsible for consolidating the company's lead position in Turkey through more in-house R&D and licensing deals with innovative companies while building a stronger regional footprint.
Pharmaceutical Executive August 1, 2011 Ben Comer	Is the 'Emerging Market' a Dated Concept? When it comes to the emerging markets, executing a few key elements of success are more important than ever.
Chemistry World August 17, 2015 Anthony King	Greek crisis puts pressure on pharmaceuticals Supplies of critical drugs to Greek pharmacies have become sparse and erratic as the economic crisis squeezes public spending
BusinessWeek October 1, 2009 Stanley Reed	Turkey's Shift to a More Open Economy Applying for EU membership has sped up reforms, and that has helped the country weather the current crisis.
BusinessWeek December 2, 2010 Norman Pearlstine	Norman Pearlstine Talks with Mehmet Sinsek An interview with Turkey's Finance Minister on why its economy is growing so fast.
BusinessWeek October 11, 2004 John Rossant	Turkey At The EU's Door Turkey's decades-long quest to join the European Union looks set to take a great leap forward. But while official pronouncements sound friendly, popular opposition is rising.
Pharmaceutical Executive January 1, 2011	The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade.
Pharmaceutical Executive May 1, 2011	Seeing Through the Transparency Directive The EU is largely powerless when it comes to policies over pharma pricing and reimbursement.
Pharmaceutical Executive December 1, 2010 Zhu Shen	China 2020: Walled In No More Pharma sets the pace for China's ambitious new innovation agenda
BusinessWeek July 29, 2010 James G. Neuger	Cameron Backs the Turks, Rattles the EU The British PM says it's time Turkey got into the European Union.
Pharmaceutical Executive September 1, 2013 William Looney	High Noon For Hot Markets Fading growth, overstretched governments, and a global governance backlash against pharma business are turning up the heat on the performance of emerging country markets.
Pharmaceutical Executive January 1, 2012 William Looney	Pharma 2012: Hard Times Before the Harvest 2012 will be a transition year for pharma, one of the most important in its history. The challenge is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
Pharmaceutical Executive September 1, 2013	T-TIPing the Balance in Industry's Favor By the start of 2014, industry expects to have a clearer idea of how far the US-EU free trade pact is going.
Pharmaceutical Executive October 1, 2006 Sarah Houlton	Global Report: Please Come Back Health authorities in Europe are working hard to reestablish their countries as preferred locations for pharma's R&D facilities. Fortunately, they've got a blueprint: China.
BusinessWeek April 15, 2010 Bryant & Holland	Turkey's Moment Its economy is hot again after a painful 2009, and some economists say it's a Germany in the making. The politics, though, are raucous.
Pharmaceutical Executive September 1, 2012 Stan Bernard	The Payer C Change: From Customers to Competitors "Payers have evolved to become powerful global contenders with pharma for increasingly limited funding of drug budgets." Understanding why and how this payer shift to dominance occurred is critical for pharmaceutical professionals in adjusting their business model.
BusinessWeek February 9, 2004 John Rossant	Turkey's EU Bid: Resistance Is On The Rise When it comes to its ally Turkey, the U.S. has long had a consistent goal: The European Union should take in the largely Muslim eastern Mediterranean nation as a full member. Back in Europe, though, that message isn't going over well.
BusinessWeek June 16, 2011 Suzy Hansen	Turkey's Moment Turkey is showing the world how a Muslim country in a turbulent region can achieve stability and prosperity. Will it last?
Chemistry World June 5, 2009 Anna Lewcock	Pharma's new world order So-called 'pharmerging' markets will contribute over half of the growth of the global pharmaceutical market this year, according to market analysts.
Pharmaceutical Executive June 1, 2011	Emerging Pharma Leaders 2011 Meet 2011's Emerging Pharma Leaders. Can these 30 trendsetters build competitive scale from scarcity?
Pharmaceutical Executive January 21, 2014 Comer & Upton	Pharm Exec's Annual Industry Outlook 2014 For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive; muddling through is so yesterday.
Pharmaceutical Executive May 1, 2007	Thoughtleader: Thomas Nagle, Strategic Pricing Group This industry consultant believes the U.S. government will soon follow Europe's lead in taking a greater hand in price negotiations, and pharma will need to be able to communicate the value that products offer. Here he discusses how pharma can meet that challenge.
BusinessWeek May 27, 2010 Ben Holland	Greece Can Learn IMF Austerity from Turkey A banking crisis in 2001 slammed the Turks, but they moved fast to carry out a tough IMF plan -- and have plenty to teach the Greeks
BusinessWeek September 26, 2005	EU And Turkey: Talks Still On Track Despite fears that they would derail, talks on Turkey's accession to the European Union are expected to begin on Oct. 3 as planned.
Pharmaceutical Executive August 1, 2012	Sunny Outlook for Biopharm 2020? Albert Wertheimer looks beyond today's dark clouds with a comparatively sunny forecast for the biopharm industry in 2020. Just watch out for the harsh light of complacency.
Pharmaceutical Executive January 1, 2009 Stan Bernard	Pharma vs. Pharma The most successful pharmaceutical companies will be those that can transform as the industry itself transforms.
Pharmaceutical Executive January 1, 2007 Glass & Poli	Forecast 2007: Connecting the Dots How do execs rank the issues facing the pharmaceutical industry? And what are the links they see between them? A new study reveals the industry's mental map of today's challenges.
The Motley Fool October 19, 2005 David Compton	Istanbul Beckons To whet your appetite in Turkish stocks, try investing in Turkey's largest mobile-phone operator and the country's only American Depositary Receipt (ADR) to be listed on the New York Stock Exchange -- Turkcell.
Pharmaceutical Executive January 1, 2012 Jill Wechsler	New Year, New Issues Look for action in 2012 on drug access, shortages, innovation, and transparency. The 800-pound gorilla in the room is the looming Supreme Court decision on the constitutionality of the Obama health reform legislation.
BusinessWeek October 31, 2005 Cooper & Madigan	Turkey: Big Blows From High Oil -- And Avian Flu If the EU issues a travel advisory against Turkey, that would severely cut into tourism revenues, which account for almost 20% of the economy.
Pharmaceutical Executive January 1, 2007 Walter Armstrong	Forecast 2007: At Sea In times of crisis, it's harder than ever to take the long view. The healing arts may be as old as humankind, but the business of pharma is still in its infancy.
Pharmaceutical Executive November 1, 2008	No Ordinary Joe It's been a year since consumer marketing master Joe Jimenez took over the top spot at Novartis Pharma. How's he faring?
Pharmaceutical Executive January 1, 2012	Compliance: Getting Those Ducks in a Row Pharma must coordinate the efforts of medical, legal, HR, global partners and many other players in the regulatory compliance space to keep itself afloat in choppy seas.
Pharmaceutical Executive January 1, 2009 Walter Armstrong	Up in the Air If pharma execs start upping their consumption of antihypertensives and anxiolytics (all branded, of course) in the months to come, it won't be a huge surprise. The industry faces a truly unprecedented number of political and policy challenges.
The Motley Fool July 25, 2011 Eric Dutram	What's Crushing the Turkey ETF? Many analysts are growing increasingly worried over the health of the Turkish economy.
Pharmaceutical Executive October 1, 2008 Patrick Clinton	Future Shock A vision of pharma's next business model is starting to emerge. But how do we get from here to there?
Pharmaceutical Executive March 1, 2011 William Looney	Making Sense of Market Chaos Pharma can be an insular industry, with limited capacity to gaze beyond its own narrow frame of vision
National Real Estate Investor May 1, 2008 Bennett Voyles	Turning Istanbul-lish Until recently, Istanbul occupied almost no space in the minds of most Western real estate investors.
Pharmaceutical Executive November 1, 2011	Turbulent Waters: M&As 2011 The latest numbers in pharma deals reveals a sector in transition, where market volatility has sharply degraded the appetite for risk.
Pharmaceutical Executive July 3, 2007 Walter Armstrong	Take Me to Your Leader Turnover in the top 10 pharmas has new CEOs racing to reinvent the way their companies do business. Running a large pharmaceutical company has becoming immensely complex, and requires a broad set of management skills. Even then, a CEO may never see a beloved molecule approved for drughood.
Pharmaceutical Executive October 1, 2005	Public Relations: Communications Delivery Chain An interview with Nanccy Turett, president of Edelman Health on how, to regain consumers' trust, pharma must better communicate its mission, goals, and policies.
Finance & Development September 1, 2000 Rene Weber & Gunther Taube	Estonia Moves Toward EU Accession Estonia's rapid transition to a market economy and integration into the world economy have intensified its economic and political ties with Western Europe. It now faces the challenge of meeting the remaining requirements for EU membership and eventual participation in EMU.
The Motley Fool February 4, 2008 Adam J. Wiederman	Best International Stock: Turkcell A quick summary of Turkcell Iletisim Hizmetleri, the dominant wireless player in Turkey's growing economy.
Pharmaceutical Executive September 1, 2010	Explaining the Drug Drought Industry needs to engage in a broader public debate on ways to rekindle the innovative engine in new drug discovery and development.
Pharmaceutical Executive December 1, 2013 Peter Young	2013 Pharma and Biotech Financial Report Big Pharma and biotech continue to need each other. But biotech is feeling slightly more confident as the options for IPOs get better.
TIME Asia July 18, 2011	Inbox Readers write in with comments on stories about taking cancer seriously and Turkey joining the European Union.
Inc. April 2007 Stephanie Clifford	Fully Committed Bulent Celebi has set up an American-style company in Turkey, where he enjoys advantages his competition can only dream of.
Pharmaceutical Executive January 1, 2007 Sarah Houlton	Global Report: No Satisfaction Germans on both sides of the political spectrum agree that their country's healthcare system needs reform. The latest attempt at change, though, doesn't really meet either side's needs.
IndustryWeek June 1, 2008 Adrienne Selko	Global Hot Spots 2008: Revealing Global Manufacturing's Best Kept Secrets When expanding your supply chains overseas, it's vital that you do your homework to understand a country's cultural and business practices.